ATE189606T1 - Behandlung von empfindlichen zähnen - Google Patents

Behandlung von empfindlichen zähnen

Info

Publication number
ATE189606T1
ATE189606T1 AT93912469T AT93912469T ATE189606T1 AT E189606 T1 ATE189606 T1 AT E189606T1 AT 93912469 T AT93912469 T AT 93912469T AT 93912469 T AT93912469 T AT 93912469T AT E189606 T1 ATE189606 T1 AT E189606T1
Authority
AT
Austria
Prior art keywords
ser
treatment
sensitive teeth
casein
dentinal hypersensitivity
Prior art date
Application number
AT93912469T
Other languages
English (en)
Inventor
Eric Charles Reynolds
Original Assignee
Univ Melbourne
Victorian Dairy Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Melbourne, Victorian Dairy Ind filed Critical Univ Melbourne
Application granted granted Critical
Publication of ATE189606T1 publication Critical patent/ATE189606T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Developing Agents For Electrophotography (AREA)
AT93912469T 1992-06-29 1993-06-29 Behandlung von empfindlichen zähnen ATE189606T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPL322192 1992-06-29
PCT/AU1993/000319 WO1994000146A1 (en) 1992-06-29 1993-06-29 Treatment for sensitive teeth

Publications (1)

Publication Number Publication Date
ATE189606T1 true ATE189606T1 (de) 2000-02-15

Family

ID=3776258

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93912469T ATE189606T1 (de) 1992-06-29 1993-06-29 Behandlung von empfindlichen zähnen

Country Status (13)

Country Link
US (1) US5981475A (de)
EP (1) EP0651652B1 (de)
JP (2) JP3762426B2 (de)
KR (1) KR100238551B1 (de)
AT (1) ATE189606T1 (de)
CA (1) CA2138991C (de)
DE (1) DE69327845T2 (de)
DK (1) DK0651652T3 (de)
ES (1) ES2144458T3 (de)
GR (1) GR3033246T3 (de)
NZ (1) NZ252959A (de)
PT (1) PT651652E (de)
WO (1) WO1994000146A1 (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0140248B1 (ko) * 1995-03-23 1998-06-15 한상기 신규한 카제인 포스포펩티드, 그것을 포함하는 카제인 및 그 제조방법
EP0748591B1 (de) * 1995-06-16 2001-10-17 Societe Des Produits Nestle S.A. Fluorierte Kasein-Mizellen
AU746314B2 (en) * 1997-03-13 2002-04-18 University Of Melbourne, The Calcium phosphopeptide complexes
AUPO566297A0 (en) * 1997-03-13 1997-04-10 University Of Melbourne, The Calcium phosphopeptide complexes
BR9809650A (pt) * 1997-05-19 2000-07-11 Colgate Palmolive Co Composição oral para remineralização dos dentes, e, processo para remineralizar porções desmineralizadas das estruturas de dentes
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
CA2381713A1 (en) * 1999-09-02 2001-03-08 Big Bear Bio, Inc. Methods and compositions for reducing serum phosphate levels
DE19961935A1 (de) * 1999-12-22 2001-06-28 Henkel Kgaa Zahnreinigungsmittel
ATE333800T1 (de) * 2000-01-27 2006-08-15 Fonterra Tech Ltd Kaugummigrundstoff
DE10010572A1 (de) * 2000-03-03 2001-09-06 Coronet Werke Gmbh Borste mit antimikrobieller Ausrüstung, Borstenware mit solchen Borsten sowie Verpackung für solche Borsten oder Borstenwaren
AUPR517701A0 (en) 2001-05-21 2001-06-14 University Of Melbourne, The Dental restorative materials
CA2469498C (en) * 2002-01-03 2009-06-02 The Procter & Gamble Company Stable oral compositions comprising casein phosphopeptide complexes and fluoride
MXPA04006542A (es) 2002-01-03 2004-10-04 Procter & Gamble Composiciones bucales estables que contienen complejos de fosfopeptido de caseina y fluooruro.
KR100445994B1 (ko) * 2002-01-21 2004-08-25 롯데제과주식회사 치아의 재석회화 촉진제
US7328706B2 (en) 2002-05-06 2008-02-12 Dynamic Mouth Devices Llc Therapeutic and protective dental device useful as an intra-oral delivery system
AUPS303202A0 (en) * 2002-06-20 2002-07-11 Pacific Biolink Pty Limited Protein based oral lubricant
NZ522071A (en) * 2002-10-18 2005-07-29 Patrick Joseph Silcock Hydrolysed casein phosphoprotein preparations for bioactive metal ion delivery and teeth remineralisation
ITMI20022408A1 (it) * 2002-11-14 2004-05-15 Aboca S P A Uso odontostomatologico di fito-complessi a base di radici di rabarbaro (specie appartenenti al genere rheum) e foglie di spinaci (spinacia oleracea l.).
US7780873B2 (en) * 2004-02-23 2010-08-24 Texas A&M University System Bioactive complexes compositions and methods of use thereof
CA2557261A1 (en) * 2004-02-23 2005-09-15 The Texas A&M University System Antioxidant compositions and methods of use thereof
EP1819313B1 (de) 2004-11-16 2010-12-29 3M Innovative Properties Company Dentalfüllstoffe und zusammensetzungen mit phosphatsalzen
KR101240883B1 (ko) 2004-11-16 2013-03-07 쓰리엠 이노베이티브 프로퍼티즈 컴파니 카제이네이트를 포함하는 치과용 충전제, 방법, 조성물
US8957126B2 (en) 2004-11-16 2015-02-17 3M Innovative Properties Company Dental compositions with calcium phosphorus releasing glass
CA2587556A1 (en) 2004-11-16 2006-05-26 3M Innovative Properties Company Dental fillers including a phosphorus containing surface treatment, and compositions and methods thereof
NZ555335A (en) 2004-11-25 2010-10-29 Univ Melbourne Phosphopeptide stabilised amorphous calcium phosphate complexes produced under acidic conditions
AR057353A1 (es) 2005-06-07 2007-11-28 Univ Melbourne Mineralizacion dental
US20060280694A1 (en) * 2005-06-09 2006-12-14 John Peldyak Composition for the mineralization of dental hard tissues and the reduction of caries-inducive microflora
US20060292090A1 (en) * 2005-06-22 2006-12-28 Deepak Sharma Oral care compositions, devices, and methods of using the same
AR057402A1 (es) 2005-06-24 2007-12-05 Univ Melbourne Complejos de fosfato de calcio estabilizados por fosfopeptidos o fosfoproteinas, proceso de obtencion y composiciones farmaceuticas
US20070048347A1 (en) * 2005-08-26 2007-03-01 Laura Bardach Intra-oral device for treating obesity
EP2705826B1 (de) 2006-02-09 2019-09-11 The University of Melbourne Fluoridzusammensetzung und Verfahren zur dentalen Mineralisierung
AU2007235445B2 (en) * 2006-04-05 2011-04-14 Intercontinental Great Brands Llc Calcium phosphate complex in acid containing confectionery
KR101039802B1 (ko) * 2008-10-08 2011-06-09 주식회사 나이벡 치아 지각과민 방지용 조성물
WO2010068359A1 (en) 2008-12-11 2010-06-17 3M Innovative Properties Company Surface-treated calcium phosphate particles suitable for oral care and dental compositions
US8632754B2 (en) 2009-08-03 2014-01-21 Mcneil-Ppc, Inc. Tooth sensitivity treatment compositions
US8603442B2 (en) 2009-08-03 2013-12-10 Mcneil-Ppc, Inc. Tooth sensitivity treatment compositions
US9060947B2 (en) 2009-08-03 2015-06-23 Mcneil-Ppc, Inc. Tooth sensitivity treatment compositions
US8658139B1 (en) 2010-02-27 2014-02-25 Squigle, Inc. Prevention and treatment of oral diseases
US12318406B2 (en) 2013-03-15 2025-06-03 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
US11000545B2 (en) 2013-03-15 2021-05-11 Cda Research Group, Inc. Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza
US11007143B2 (en) * 2013-03-15 2021-05-18 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body
US11083750B2 (en) 2013-03-15 2021-08-10 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
US11318089B2 (en) 2013-03-15 2022-05-03 Cda Research Group, Inc. Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body
US10398733B2 (en) 2013-03-15 2019-09-03 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body
MX378581B (es) 2013-07-23 2025-03-10 Univ Melbourne Composiciones y metodos para la mineralizacion dental.
ES2959412T3 (es) 2013-12-24 2024-02-26 Univ Melbourne Composiciones estañosas estabilizadas
KR102076268B1 (ko) * 2015-04-17 2020-02-11 주식회사 엘지생활건강 구강용 조성물
US10575976B2 (en) 2015-04-30 2020-03-03 Dynamic Mouth Devices, L.L.C. Method and apparatus for weight management utilizing an intra-oral device
KR101772449B1 (ko) 2016-12-27 2017-08-30 주식회사 하이센스바이오 신규한 펩타이드
EA201991935A1 (ru) 2017-03-14 2020-02-14 Де Юниверсити Оф Мельбурн Комплексы для лечения чувствительности
EA201991933A1 (ru) 2017-03-14 2020-03-05 Де Юниверсити Оф Мельбурн Лечение гингивита
US11193184B2 (en) 2019-02-22 2021-12-07 Cda Research Group, Inc. System for use in producing a metal ion suspension and process of using same
US12569417B2 (en) 2019-03-13 2026-03-10 The University Of Melbourne Compositions and methods for promoting mineralization

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5130123A (en) * 1981-03-04 1992-07-14 The University Of Melbourne Dentifrice
NZ199891A (en) * 1981-03-04 1985-07-31 Univ Melbourne Caries-inhibiting compositions containing casein or x-s-casein or phosuitin
AU575035B2 (en) * 1983-12-22 1988-07-21 University Of Melbourne, The Caries and gingivitis inhibiton using casein derivative
CA1315480C (en) * 1986-06-12 1993-03-30 Eric Charles Reynolds Phosphopeptides
US5227154A (en) * 1991-08-22 1993-07-13 The University Of Melbourne Phosphopeptides for the treatment of dental calculus

Also Published As

Publication number Publication date
JPH07509224A (ja) 1995-10-12
JP2005336211A (ja) 2005-12-08
KR950702123A (ko) 1995-06-19
JP3762426B2 (ja) 2006-04-05
DE69327845D1 (de) 2000-03-16
EP0651652B1 (de) 2000-02-09
EP0651652A1 (de) 1995-05-10
CA2138991A1 (en) 1994-01-06
DK0651652T3 (da) 2000-07-24
PT651652E (pt) 2000-07-31
WO1994000146A1 (en) 1994-01-06
US5981475A (en) 1999-11-09
GR3033246T3 (en) 2000-09-29
DE69327845T2 (de) 2000-10-26
EP0651652A4 (de) 1996-10-23
KR100238551B1 (ko) 2000-02-01
CA2138991C (en) 2007-01-30
NZ252959A (en) 1996-06-25
ES2144458T3 (es) 2000-06-16

Similar Documents

Publication Publication Date Title
ATE189606T1 (de) Behandlung von empfindlichen zähnen
CA1264740C (en) Tetrapyrrole therapeutic agents
DE3265634D1 (en) Renin inhibitory peptides
DE59309786D1 (de) Enniatine und enniatinderivate zur bekämpfung von endoparasiten
ATE87199T1 (de) Mittel zur mundhygiene.
ATE73459T1 (de) Pharmazeutische zusammensetzungen, welche ein dipeptid enthalten.
IT1255258B (it) Composizioni farmaceutiche per l'applicazione per via nasale.
DE3683528D1 (de) Tetrapyrrol-therapiemittel.
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
DE3381282D1 (de) Peptidverbindungen.
TR199701654T1 (xx) 4-Fenilaminotiyazol t�revleri.
DE50313067D1 (de) Induzierte remineralisation von humanem zahnschmelz
ATE72963T1 (de) Konditionierfluessigkeiten von zahn- oder knochensubstanz.
RU94046434A (ru) Новые пептиды, способ их получения и их применение
IT1163037B (it) Procedimento di sintesi di peptidi e agenti di bloccaggio di amminoacidi
MY106904A (en) Herbicidal composition.
ATE42308T1 (de) Pharmakologisch aktive peptide.
DE3673689D1 (de) Zusammensetzung eines acrylcopolymers und adhaesive ueberzuege aus dieser zusammensetzung.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
SE8203054L (sv) Antihypertensivt medel
AU1300283A (en) Chromophoric peptides
ES2096559T3 (es) Interferon gamma humano, procedimiento para la preparacion de dicho interferon gamma humano, y su uso.
ATE113843T1 (de) Verwendung eines prolylendopeptidase-inhibitors zur behandlung von aids.
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
KR890701118A (ko) 혈소판 감소증 예방 및 치료제

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties